2094P A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant and olanzapine for highly emetogenic chemotherapy in breast cancer
| Autor: | Takada, S., Tsuji, D., Kawaguchi, T., Yokokawa, T., Kawasaki, Y., Yamaguchi, T., Tamaki, S., koizumi, K., Matsumoto, T., Sakata, Y., Arakawa, Y., Ayuhara, H., Yamaguchi, M., Suzuki, W., Watanabe, K-I., Hosonaga, M., Nakagaki, S., Hatori, M., Osawa, M., Suzuki, K. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1100-S1100 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|